【摘要】：目的:了解醫(yī)院抗菌藥物應(yīng)用和臨床主要致病菌耐藥情況,為細菌感染性疾病治療和抗菌藥物合理應(yīng)用提供依據(jù)。方法:統(tǒng)計咸陽市中心醫(yī)院2011-2013年住院患者抗菌藥物的消耗金額和用藥頻度(DDDs),并對同期臨床送檢標本進行細菌培養(yǎng)鑒定及藥敏試驗,分析其結(jié)果。結(jié)果:2011-2013年,頭孢菌素類、β-內(nèi)酰胺酶抑制劑復(fù)方制劑和其他β-內(nèi)酰胺類抗菌藥物的消耗金額始終排在各類抗菌藥物的前3位,喹諾酮類所占銷售金額的比例逐年下降,但其代表品種左氧氟沙星的DDDs在2013年出現(xiàn)上升且排序提前。表皮葡萄球菌居醫(yī)院感染葡萄球菌中的第1位,始終位列分離病原菌的前3位,對很多藥物的耐藥率達50%以上。大腸埃希菌、肺炎克雷伯菌和銅綠假單胞菌是分離出的主要革蘭陰性菌,對多種抗菌藥物具有不同程度的耐藥性。結(jié)論:該院的細菌耐藥形勢嚴峻,應(yīng)根據(jù)藥敏結(jié)果謹慎選擇抗菌藥物以進一步提高臨床療效。
[Abstract]:Aim: to understand the application of antibiotics in hospital and the drug resistance of major clinical pathogens in order to provide the basis for the treatment of bacterial infectious diseases and the rational use of antibiotics. Methods: the consumption and frequency of antibacterial drugs in the inpatients of Xianyang Central Hospital from 2011 to 2013 were counted and the bacterial culture identification and drug sensitivity test were carried out on the samples sent for clinical examination at the same time. The results were analyzed. Results: from 2011 to 2013, the consumption of cephalosporins, 尾-lactamase inhibitor compound preparations and other 尾-lactam antibiotics ranked among the top 3 antibiotics. The proportion of quinolones in sales declined year by year, but the DDDs of levofloxacin, a representative of quinolones, increased and ranked earlier in 2013. Staphylococci epidermidis ranked first among hospital-infected staphylococci and always ranked among the top three isolated pathogens. The drug-resistant rate of Staphylococcus epidermidis to many drugs was more than 50%. Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa are the major gram-negative bacteria isolated and have different degrees of drug resistance to a variety of antimicrobial agents. Conclusion: the situation of bacterial drug resistance in this hospital is serious, and antibiotics should be carefully selected according to the results of drug sensitivity in order to further improve the clinical efficacy.
【作者單位】： 陜西中醫(yī)學(xué)院;咸陽市中心醫(yī)院;
【分類號】：R95

【參考文獻】

相關(guān)期刊論文 前3條

1 王偉佳;張秀明;;耐藥表皮葡萄球菌生物被膜形成前、后差異蛋白表達的分析[J];國際檢驗醫(yī)學(xué)雜志;2013年23期

2 林驚世;顧晟琰;蔣震媚;;喹諾酮類抗菌藥的耐藥機制及其研究進展[J];海峽藥學(xué);2012年09期

3 李柳琴;饒富順;;表皮葡萄球菌112株耐藥性分析[J];檢驗醫(yī)學(xué)與臨床;2013年06期

【共引文獻】

相關(guān)期刊論文 前10條

1 宋tq;王鳳蘋;米嬌;李燕;;表皮葡萄球菌luxS基因敲除重組質(zhì)粒的構(gòu)建[J];成都醫(yī)學(xué)院學(xué)報;2013年01期

2 文秀蘭;唐榮德;馮國新;張燕珊;;骨傷科住院患者MRSE和MRSA感染連續(xù)五年耐藥分析[J];國際檢驗醫(yī)學(xué)雜志;2013年16期

3 賀丹丹;黃良宗;陳孝杰;楊銅;饒麗麗;羅東妹;陳佩玲;彭輝;劉健華;;不同動物源大腸桿菌的耐藥性調(diào)查[J];中國畜牧獸醫(yī);2013年10期

4 鄭紅青;黨曉鵬;由秀玲;;CTX-M型超廣譜β-內(nèi)酰胺酶對細菌耐藥性的影響[J];當代畜牧;2013年30期

5 楊帆;王明華;;值得期待的新β內(nèi)酰胺酶抑制劑阿維巴坦及其復(fù)合制劑[J];第三軍醫(yī)大學(xué)學(xué)報;2013年23期

6 宋靜靜;張群智;;尿路感染病原菌分布及大腸埃希菌的耐藥性分析[J];大理學(xué)院學(xué)報;2013年12期

7 胡志軍;潘曉龍;周東升;唐吉斌;崇慧峰;張盛;呂e，

本文編號：2439821